ToxSci Advance Access published online on July 26, 2007
Toxicological Sciences, doi:10.1093/toxsci/kfm188
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Low and Non-Toxic Inorganic Mercury Burdens Attenuate BCR-Mediated Signal Transduction



,
* Department of Environmental Medicine, University of Rochester, Rochester NY
Department of Immunology and Microbiology, Wayne State University, Detroit, MI
Department of Pharmacology, Wayne State University, Detroit, MI
Address correspondence and reprint requests to Allen J. Rosenspire, Department of Immunology and Microbiology, 7374 Scott Hall, Wayne State University School of Medicine, Detroit, MI 48201, E-mail: arosenspire{at}wayne.edu
Received May 18, 2007; revision received July 14, 2007; accepted July 18, 2007
| Abstract |
|---|
The ubiquitous environmental heavy metal contaminant mercury (Hg) is a potent immunomodulator that has been implicated as a factor contributing to autoimmune disease. However, the mechanism(s) whereby Hg initiates or perpetuates autoimmune responses, especially at the biochemical/molecular level, remain poorly understood. Recent work has established a relationship between impaired B Cell Receptor (BCR) signal strength and autoimmune disease. In previous studies we have shown that in mouse WEHI-231 B cells, non-cytotoxic concentrations of inorganic mercury (Hg+2) interfered with BCR-mediated growth control, suggesting that BCR signal strength was impaired by Hg+2. ERK 1,2 MAPK is responsible for the activation of several transcription factors in B cells. Phosphorylation of ERK serves as an essential node of signal integration for the BCR. Thus, the magnitude of ERK activation serves as an operational metric for BCR signal strength. Using Western blotting and phosphospecific flow cytometry, we now show that the kinetics and magnitude of BCR mediated activation of ERK MAP kinase are markedly attenuated in WEHI-231 cells and splenic B cells that have been exposed to low and non-toxic burdens of Hg+2. However, Hg+2 does not seem to act directly on ERK MAP kinase but rather on an upstream element or elements of the BCR signal transduction pathway, above the level of the key protein tyrosine kinase Syk. Our data suggest that the site of action of Hg+2 may very well be localized on the plasma membrane. These findings support a connection between Hg+2 and attenuated BCR signal strength in the etiology of autoimmune disease.
Key Words: Mercury; B Cell Receptor; ERK, Syk.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S.-R. Yang, H. Yao, S. Rajendrasozhan, S. Chung, I. Edirisinghe, S. Valvo, G. Fromm, M. J. McCabe Jr., P. J. Sime, R. P. Phipps, et al. RelB Is Differentially Regulated by I{kappa}B Kinase-{alpha} in B Cells and Mouse Lung by Cigarette Smoke Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 147 - 158. [Abstract] [Full Text] [PDF] |
||||
